Phadia to Use Aushon 2470 Arrayer for Development of Allergen and Autoimmunity Diagnostics
June 25, 2010
Phadia to Use Aushon 2470 Arrayer for Development of Allergen and Autoimmunity Diagnostics
The company's Multiplexing Diagnostics division will use the arrayer to develop molecular tools, including protein biomarkers, to diagnose allergy and autoimmunity.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Thermo Fisher Adds to Specialty-Dx Business with $3.5B Phadia Buy
May 20, 2011 / ProteoMonitor - Van Andel Research Institute To Run In-House Protein Arrays on Aushon BioSystems' 2470 Platform
May 14, 2010 / ProteoMonitor - Aushon Inks Deal with Peking University to ID Protein Biomarkers for Colorectal Cancer
February 11, 2011 / ProteoMonitor - ASU Biodesign Scientists Hope to Apply Direct-to-Consumer Model to Proteomics Testing
February 4, 2011 / ProteoMonitor - Proteomics Firms Net More than $8.75M in IRS Funds; Bulk of Awards Aimed at Diagnostics Work
November 5, 2010 / ProteoMonitor